Поиск

Автор

Ключевое слово

Коллекция

Дополнительно:

Период публикации

Научный руководитель

Оппонент

По вашему запросу найдено документов: 147

Страница 1 из 15

Safety and Efficacy of Lonapegsomatropin in Children With Growth Hormone Deficiency: enliGHten Trial 2-Year Results

. Endpoints were long-term safety, annualized height velocity, pharmacodynamics [insulin-like growth factor-1

Инсулиноподобный фактор роста-1 и ремоделирование миокарда у мужчин с хронической сердечной недостаточностью ишемического генеза

Insulin-like Growth Factor-1 and Myocardial Remodeling in Patients with Chronic Heart Failure of Ischemic Origin

Zakirova, A.N., Zakirova, N.E., Nizamova, D.F., Закирова А.Н., Закирова Н.Э., Низамова Д.Ф. (2022)

Aim. To study the presence and nature of correlations between the level of Insulin-like growth

ТРАНСФОРМИРУЮЩИЙ ФАКТОР РОСТА β1 И РЕМОДЕЛИРОВАНИЕ МИОКАРДА У ПАЦИЕНТОВ С ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ ИШЕМИЧЕСКОГО ГЕНЕЗА

TRANSFORMING GROWTH FACTOR β1 AND MYOCARDIAL REMODELING IN PATIENTS WITH CHRONIC HEART FAILURE OF ISCHEMIC GENESIS

ЗАКИРОВА, Н.Э., ЗАКИРОВА, А.Н., НИЗАМОВА, Д.Ф., ZAKIROVA, N.E., ZAKIROVA, A.N., NIZAMOVA, D.F. (2021)

TRANSFORMING GROWTH FACTOR β1 AND MYOCARDIAL REMODELING IN PATIENTS WITH CHRONIC HEART FAILURE

Blue LED causes autophagic cell death in human osteosarcoma by increasing ROS generation and dephosphorylating EGFR

diphenyleneiodonium (DPI) blocked suppression of OS cell growth, indicating that ROS accumulation might play

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Coignard, J., Lush, M., Beesley, J., O’Mara, T.A., Dennis, J, Tyrer, J.P., Barnes, D.R., McGuffog, L., Leslie, G., Bolla, M.K., Adank, M.A., Kiiski, J.I., Nevanlinna, H., team of authors (2021)

factors. About 50 common variants have been shown to modify BC risk for mutation carriers. All but three

THE ROLE OF LONG NONCODING RNAS IN THE BIOLOGY OF PITUITARY ADENOMAS

BEILERLI, O.A., GAREEV, I.F., V.N. Pavlov, CHEN, X., ZHAO, S. (2020)

RNAs that function as regulatory factors have been identified for several complex cellular processes, such as cell

LONG-ACTING C-TERMINAL PEPTIDE-MODIFIED HGH (MOD-4023): RESULTS OF A SAFETY AND DOSE-FINDING STUDY IN GHD CHILDREN

Zelinska, N., Iotova, V., Skorodok, J., Malievsky, O., Peterkova, V., Samsonova, L., Rosenfeld, Ron G., Zadik, Zvi, Jaron-Mendelson, Michal, Koren, Ronit, Amitzi, Leanne, Raduk, Dmitri, Hershkovitz, Oren, Hart, Gili (2017)

fivefold to 10-fold longer when compared with daily r-hGH. Insulin-like growth factor (IGF)-I and IGF

A RANDOMIZED PHASE 2 STUDY OF LONG-ACTING TRANSCON GH VS DAILY GH IN CHILDHOOD GH DEFICIENCY

Chatelain, Pierre, Malievskiy, Oleg, Radziuk, Klaudziya, Senatorova, Ganna, Abdou, Magdy O., Vlachopapadopoulou, Elpis, Skorodok, Yulia, Peterkova, Valentina, Leff, Jonathan A., Beckert, Michael (2017)

/kg/d for 26 weeks. Main Outcome Measures: GH and insulinlike growth factor-1 (IGF-1) levels, growth, adverse

Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study

Deal, C, Steelman, J, Vlachopapadopoulou, E, Stawerska, R, Silverman, LA;, Phillip, M, Kim, HS, Ko, CW, Malievskiy, O, Cara, JF, Roland, CL, Taylor, CT, Valluri, SR, Wajnrajch, MP, Pastrak, A, Miller, BS (2022)

Context: Somatrogon is a long-acting recombinant human growth hormone (rhGH) in development

Regulation of cardiomyocyte fate plasticity: a key strategy for cardiac regeneration

Gong, R., Jiang, Z., Zagidullin, N., Liu, T., Cai, B. (2021)

by the modifications of cell cycle-related genes or regulation of growth-related signals. Additionally, non

Страница 1 из 15